CCI approves acquisition of Kenvue Inc. by Kimberly-Clark (See 'Corp Brief') CCI approves Adani Power to buy stake of GVK Energy (See 'Corp Brief') IBC - If transaction was builder-linked contractual arrangement rather than pure financial debt default, Section 7 IBC proceedings cannot be used in parallel with DRT recovery proceedings: SC (See 'Legal Desk') CCI approves acquisition of stake in Llyods Engineering by Thriveni Earthmovers (See 'Corp Brief') CCI approves acquisition by CPPIB India in Ctrl S Datacenters (See 'Corp Brief') Govt pushes India Post toward Corporate-Style Efficiency (See 'Corp Brief') IPR - Use of house mark does not by itself obviate infringement or passing off: HC (See 'Legal Desk') Present petro conservation intended towards long-run capacity building: RM (See 'Corp Brief') Atal Innovation Mission hosts AIM Sumvaad- Central India to strengthen regional incubators (See 'Corp Brief') FERA - Foreign judgment is unenforceable in India as it fell within exceptions u/s 13 CPC: SC (See 'Legal Desk') Forum of Regulators celebrates 21 Years of strengthening India's Power Sector (See 'Corp Brief') A&C - Once seat of arbitration is expressly designated by agreement of parties, that seat becomes juridical home of arbitration and operates akin to exclusive jurisdiction clause: SC (See 'Legal Desk') Supreme Court lays down scenarios for lifting of Doctrine of Corporate Veil (See 'CORP EINSICHTf') Fisheries Secy visits ornamental fish brood bank in Maharashtra (See 'Corp Brief') Company Law - For purpose of maintainability of petitions u/s 397 & 398, expression ‘member' is not to be confined only to formal entry in register of members u/s 41(2): SC (See 'Legal Desk') Over 3,500 Participants compete in AB PM-JAY Hackathon (See 'Corp Brief') Scindia, Fadnavis inaugurate renovated Andheri RS Post Office as Future-Ready Service Hub (See 'Corp Brief') IBC - While subsidiary companies are separate legal entities, corporate veil may be lifted if associated companies are inextricably connected so as to form one concern: SC (See 'Legal Desk')

Print

Govt issues updated management protocol for managing COVID-19 cases

Published: Jun 27, 2020

By TIOLCORPLAW News Service

NEW DELHI, JUNE 27, 2020: Keeping pace with evolving knowledge about COVID-19, especially in terms of effective drugs, the Union Ministry of Health & Family Welfare has today released an updated clinical management protocol for managing COVID-19 cases. The updated protocol includes the advice to use Dexamethasone as an alternative choice to Methylprednisolone for managing moderate to severe cases of COVID-19. The change has been made after considering the latest available evidence and expert consultation.

Dexamethasone is a corticosteroid drug used in a wide range of conditions for its anti-inflammatory and immunosuppressant effects. The drug has been tested in hospitalized patients with COVID-19 in the RECOVERY clinical trial and was found to have benefits for critically ill patients and has been shown to reduce mortality by about one third for patients on ventilators, and by about one fifth for patients being maintained on oxygen therapy. The drug is also a part of the National List of Essential Medicines (NLEM) and is widely available.

The Union Health Secretary, Ms Preeti Sudan, has forwarded the updated protocol with all States/UTs to make necessary arrangements for availability and use of the updated protocol and drug Dexamethasone at the institutional level also. The guidance document has also been made available online on the website of the Health Ministry at:

https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19dated27062020.pdf

The last update to the clinical management protocol was done on 13th June, 2020.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.